MKI67 and triple-negative breast carcinoma: <h4>Objectives</h4>To evaluate the diagnostic value of multimodal MRI by comprising quantitative mapping, diffusion-weighted imaging (DWI), and dynamic contrast-enhanced MRI (DCE-MRI) in differentiating triple-negative breast cancer (TNBC) from non-TNBC, and to investigate the correlation between significant quantitative mapping parameters and the Ki-67 proliferation index.<h4>Methods</h4>This prospective study enrolled 120 patients with invasive breast cancer (30 TNBC and 90 non-TNBC) who underwent preoperative quantitative mapping, DWI, and DCE-MRI.